Patterns of treatment in men with intermediate-, high-, and very high-risk prostate cancer according to their modelled life expectancy

被引：0
|
作者：
Irenaeus, S. [1 ]
Garmo, H. [2 ]
Gedeborg, R. [2 ]
Robinson, D. [3 ]
Stattin, P. [2 ]
Beckmann, K. [4 ]
机构：
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[2] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[3] Highland Hosp, Dept Urol, Eksjo, Sweden
[4] Univ South Australia, Canc Epidemiol & Populat Hlth Res Grp, Adelaide, SA, Australia
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0424
引用
收藏
页码：S1265 / S1266
页数：2
相关论文
共 50 条
  • [31] The role of proton beam therapy for patients with intermediate- and high-risk prostate cancer.
    Arimura, Takeshi
    Kondo, Naoaki
    Matsukawa, Kyoko
    Wada, Kiyotaka
    Kitano, Ikumi
    Chuman, Ikuko
    Nagata, Ichiro
    Ogino, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Intermediate- and high-risk melanoma.
    Agarwala S.S.
    Current Treatment Options in Oncology, 2002, 3 (3) : 205 - 217
  • [33] Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
    Lee, Hye Won
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (11) : 1631 - 1637
  • [34] Optimal treatment for intermediate- and high-risk, nonmuscle-invasive bladder cancer
    van der Meijden, A. P. M.
    THESCIENTIFICWORLDJOURNAL, 2006, 6 : 2611 - 2616
  • [35] INTERMEDIATE-TERM OUTCOMES IN MEN WITH VERY HIGH RISK PROSTATE CANCER
    Tosoian, Jeffrey
    Sundi, Debasish
    Chapin, Brian
    Karnes, R. Jeffrey
    Antonarakis, Emmanuel
    Chappidi, Meera
    Alam, Ridwan
    Glavaris, Stephanie
    Ghabili, Kamyar
    Allaf, Mohamed
    Bivalacqua, Trinity
    Pienta, Kenneth
    Phuoc Tran
    Schaeffer, Edward
    Ross, Ashley
    JOURNAL OF UROLOGY, 2016, 195 (04): : E989 - E989
  • [36] Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials
    Nguyen, Paul L.
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2055 - 2056
  • [37] Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment
    Reichard, Chad A.
    Hoffman, Karen E.
    Tang, Chad
    Williams, Stephen B.
    Allen, Pamela K.
    Achim, Mary F.
    Kuban, Deborah A.
    Chapin, Brian F.
    BJU INTERNATIONAL, 2019, 124 (05) : 811 - 819
  • [38] Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer, and confusion about the results of the randomized trials
    Roach, Mack, III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3816 - 3817
  • [39] Survival following primary androgen deprivation therapy for localized intermediate- or high-risk prostate cancer: comparison with the life expectancy of the age-matched normal population
    Matsumoto, Kazuhiro
    Hagiwara, Masayuki
    Tanaka, Nobuyuki
    Hayakawa, Nozomi
    Ishida, Masaru
    Ninomiya, Akiharu
    Nakajima, Yosuke
    Nakamura, So
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [40] Survival following primary androgen deprivation therapy for localized intermediate- or high-risk prostate cancer: comparison with the life expectancy of the age-matched normal population
    Kazuhiro Matsumoto
    Masayuki Hagiwara
    Nobuyuki Tanaka
    Nozomi Hayakawa
    Masaru Ishida
    Akiharu Ninomiya
    Yosuke Nakajima
    So Nakamura
    Medical Oncology, 2014, 31
12345